Jeffrey James Barry, MD
Orthopedic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 9
- Since medical school
- 14 years
- Graduated 2012
Offices
9 locations · University of California San Francisco · UCSF Medical Group Business Services · Regents Univ of California UCSF
Hospitals listed: 057031 · 058189 · 059551 · Marinhealth Medical Center · Novato Community Hospital · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barry’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A128858 · Current
Licensed to practise in California · since 2014 · expires 2028-01-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$396,047
Medicare paid this office $396,047 for 710 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of thigh bone and hip joint with prosthesis | 110 | $129,774 | $1,119 |
| Replacement of knee joint, both sides of knee | 82 | $96,273 | $1,133 |
| Return visit (30+ min) | 357 | $35,274 | $87 |
| New patient visit (45+ min) | 210 | $23,951 | $114 |
| Revision of thigh bone and hip joint prosthesis | 13 | $23,699 | $1,580 |
See all 14 services
| Replacement of thigh bone and hip joint with prosthesis | 110 | $129,774 | $1,119 |
| Replacement of knee joint, both sides of knee | 82 | $96,273 | $1,133 |
| Return visit (30+ min) | 357 | $35,274 | $87 |
| New patient visit (45+ min) | 210 | $23,951 | $114 |
| Revision of thigh bone and hip joint prosthesis | 13 | $23,699 | $1,580 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 11 | $16,779 | $1,525 |
| Total hip replacement after previous hip surgery | 11 | $15,780 | $1,435 |
| Short return visit (20+ min) | 103 | $6,467 | $62 |
| Aspiration and/or injection of fluid from large joint | 113 | $6,266 | $47 |
| New patient visit (60+ min) | 37 | $5,893 | $159 |
| Long return visit (40+ min) | 23 | $3,117 | $130 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 61 | $2,629 | $43 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 88 | $1,278 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $74 | None |
Procedures Medicare counted
| Hip replacement | 177 | More than 99% of doctors who do this |
| Knee replacement | 88 | More than 91% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 36 | 50 | 77 | 139 | 134 | 132 |
| Replacement of thigh bone and hip joint with prosthesis | 23 | 34 | 45 | 48 | 90 | 116 |
| Replacement of knee joint, both sides of knee | 15 | 24 | 53 | 53 | 72 | 85 |
| Revision of thigh bone and hip joint prosthesis | – | – | – | – | 18 | 15 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | – | – | – | 14 | – | 11 |
| Total hip replacement after previous hip surgery | – | – | – | – | – | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
710 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 9% · Women 63% · Also on Medicaid 19% · Health risk score 1.18. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 65% · Depression 25% · Coronary heart disease 21% · Cancer 18% · Diabetes 16% · Atrial fibrillation 16% · Chronic kidney disease 15% · Heart failure 12% · COPD 11% · Stroke 5% · Dementia 3%.
The office billed $2,875,607, Medicare allowed $507,214 and paid $396,047; for 1,882 services of 36 kinds; $1,397 of it was for drugs given in the office and $394,650 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 710 | 1,882 | 74 | 1.18 | $2,875,607 | $396,047 |
| 2023 | 621 | 2,009 | 73 | 1.22 | $2,196,771 | $324,842 |
| 2022 | 508 | 1,479 | 73 | 1.22 | $1,627,668 | $258,842 |
| 2021 | 318 | 934 | 73 | 1.37 | $1,314,215 | $206,367 |
| 2020 | 220 | 607 | 72 | 1.38 | $921,208 | $148,458 |
| 2019 | 174 | 505 | 72 | 1.65 | $678,688 | $109,803 |
| 2018 | 237 | 354 | 75 | 1.59 | $414,606 | $72,591 |
| 2017 | 129 | 184 | 74 | 1.23 | $184,392 | $34,630 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 88 | $100,950 | $1,122 |
| Replacement of knee joint, both sides of knee | 70 | $83,670 | $1,162 |
| Return visit (30+ min) | 299 | $30,203 | $86 |
| Revision of thigh bone and hip joint prosthesis | 15 | $30,137 | $1,674 |
| New patient visit (45+ min) | 194 | $22,595 | $116 |
| Aspiration and/or injection of fluid from large joint | 109 | $6,506 | $49 |
| Short return visit (20+ min) | 94 | $5,868 | $60 |
| New patient visit (60+ min) | 31 | $4,827 | $156 |
| Long return visit (40+ min) | 27 | $3,581 | $128 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 37 | $168 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 37 | $21 | None |
2022: 10 services
| Replacement of knee joint, both sides of knee | 49 | $61,275 | $1,156 |
| Replacement of thigh bone and hip joint with prosthesis | 48 | $54,030 | $1,126 |
| Return visit (30+ min) | 234 | $27,359 | $99 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 13 | $21,653 | $1,547 |
| New patient visit (45+ min) | 145 | $19,621 | $135 |
| Aspiration and/or injection of fluid from large joint | 103 | $6,610 | $48 |
| Long return visit (40+ min) | 37 | $5,210 | $141 |
| Short return visit (20+ min) | 72 | $5,028 | $65 |
| New patient visit (60+ min) | 28 | $4,860 | $174 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | $288 | None |
2021: 11 services
| Replacement of knee joint, both sides of knee | 50 | $62,346 | $1,176 |
| Replacement of thigh bone and hip joint with prosthesis | 43 | $51,857 | $1,152 |
| Return visit (30+ min) | 122 | $14,268 | $100 |
| New patient visit (45+ min) | 64 | $8,189 | $128 |
| Long return visit (40+ min) | 44 | $5,876 | $131 |
| Aspiration and/or injection of fluid from large joint | 62 | $4,032 | $52 |
| New patient visit (60+ min) | 18 | $3,235 | $180 |
| Short return visit (20+ min) | 41 | $2,912 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $863 | $72 |
| New patient visit (30+ min) | 11 | $659 | $60 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $118 | None |
2020: 9 services
| Replacement of thigh bone and hip joint with prosthesis | 31 | $42,592 | $1,253 |
| Replacement of knee joint, both sides of knee | 24 | $30,312 | $1,263 |
| Long return visit (40+ min) | 84 | $10,698 | $109 |
| Return visit (30+ min) | 40 | $3,321 | $77 |
| New patient visit (60+ min) | 18 | $2,912 | $162 |
| New patient visit (45+ min) | 24 | $2,867 | $119 |
| Aspiration and/or injection of fluid from large joint | 39 | $2,435 | $49 |
| Short return visit (20+ min) | 34 | $1,931 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $84 | None |
2019: 8 services
| Replacement of thigh bone and hip joint with prosthesis | 23 | $28,870 | $1,255 |
| Replacement of knee joint, both sides of knee | 13 | $18,508 | $1,234 |
| Long return visit (40+ min) | 69 | $7,825 | $102 |
| New patient visit (45+ min) | 50 | $5,343 | $107 |
| New patient visit (60+ min) | 17 | $2,870 | $169 |
| Return visit (30+ min) | 21 | $1,731 | $79 |
| Aspiration and/or injection of fluid from large joint | 32 | $1,653 | $46 |
| Short return visit (20+ min) | 18 | $1,062 | $53 |
2018: 12 services
| Replacement of knee joint, both sides of knee | 58 | $10,594 | $180 |
| Replacement of thigh bone and hip joint with prosthesis | 27 | $9,680 | $346 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 12 | $6,313 | $526 |
| Revision of thigh bone and hip joint prosthesis | 11 | $5,471 | $456 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,379 | $156 |
| Revision of component of total knee joint prosthesis | 13 | $3,251 | $250 |
| New patient visit (45+ min) | 18 | $2,133 | $118 |
| Long return visit (40+ min) | 20 | $2,106 | $100 |
| Short return visit (20+ min) | 15 | $705 | $47 |
| X-ray of both hips, 3-4 views | 22 | $607 | $25 |
| Aspiration and/or injection of fluid from large joint | 11 | $529 | $41 |
| X-ray of thigh bone, minimum 2 views | 11 | $178 | $15 |
2017: 4 services
| Replacement of knee joint, both sides of knee | 38 | $6,333 | $167 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 13 | $4,222 | $325 |
| Replacement of thigh bone and hip joint with prosthesis | 14 | $3,210 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,728 | $144 |
Medicaid work
$4,712 in 2024
Medicaid paid $4,712 for 43 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 43 | $4,712 |
| 2024 | 43 | 1 | 15 | $4,712 |
| 2023 | 29 | 1 | 14 | $1,744 |
| 2022 | 43 | 1 | 17 | $3,569 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 29 | $1,744 |
2022
| Return visit (30+ min) | 43 | $3,569 |
Drugs they prescribed that Part D paid
$4,185
Pharmacies billed $4,185 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (32 of 249) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
248 generic and fewer than 11 brand-name prescriptions · $4,185 in drug cost · 21 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 32 | $1,398 | $44 |
| Meloxicam | 116 | $259 | $2 |
| Oxycodone | 22 | $147 | $7 |
| Gabapentin | 16 | $95 | $6 |
Year by year
| 2024 | 249 | 105 | 13% (32) | None | $4,185 |
| 2023 | 206 | 100 | 12% (25) | None | $4,877 |
| 2022 | 214 | 98 | 19% (41) | None | $5,817 |
| 2021 | 218 | 77 | 20% (43) | None | $4,514 |
| 2020 | 227 | 83 | 20% (46) | 8% | $4,793 |
| 2019 | 220 | 63 | 23% (50) | 10% | $8,270 |
| 2018 | 121 | 70 | 65% (79) | None | $2,531 |
| 2017 | 97 | 58 | 83% (80) | None | $1,353 |
| 2016 | 21 | 16 | 57% (12) | None | $266 |
| 2014 | 17 | 12 | 94% (16) | None | $499 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Celecoxib | 39 | $2,644 | $68 |
| Diclofenac | 16 | $551 | $34 |
| Meloxicam | 78 | $401 | $5 |
| Gabapentin | 11 | $120 | $11 |
| Oxycodone | 17 | $108 | $6 |
2022: 5 drugs
| Celecoxib | 14 | $711 | $51 |
| Oxycodone | 27 | $262 | $10 |
| Diclofenac | 19 | $247 | $13 |
| Meloxicam | 59 | $198 | $3 |
| Gabapentin | 26 | $163 | $6 |
2021: 5 drugs
| Lansoprazole | 16 | $1,294 | $81 |
| Gabapentin | 37 | $380 | $10 |
| Diclofenac | 24 | $237 | $10 |
| Meloxicam | 62 | $197 | $3 |
| Oxycodone | 18 | $177 | $10 |
2020: 5 drugs
| Diclofenac | 18 | $336 | $19 |
| Lansoprazole | 11 | $265 | $24 |
| Gabapentin | 36 | $242 | $7 |
| Meloxicam | 49 | $233 | $5 |
| Oxycodone | 28 | $232 | $8 |
2019: 6 drugs
| Diclofenac | 16 | $542 | $34 |
| Gabapentin | 30 | $350 | $12 |
| Celecoxib | 12 | $285 | $24 |
| Oxycodone | 23 | $185 | $8 |
| Meloxicam | 40 | $107 | $3 |
| Tramadol | 18 | $82 | $5 |
2018: 3 drugs
| Oxycodone | 36 | $373 | $10 |
| Tramadol | 37 | $184 | $5 |
| Meloxicam | 13 | $47 | $4 |
2017: 2 drugs
| Oxycodone | 37 | $574 | $16 |
| Tramadol | 34 | $144 | $4 |
Money from drug and device companies
$58,369 in 2025
| 2025 | 5 | 59 | $50,488 | $58,369 |
| 2024 | 4 | 58 | $54,210 | $62,082 |
| 2023 | 5 | 50 | $39,954 | $46,467 |
| 2022 | 2 | 57 | $45,243 | $54,249 |
| 2021 | 2 | 3 | None | $231 |
| 2020 | 1 | 2 | None | $37 |
| 2019 | 5 | 17 | None | $6,999 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Real Intelligence | $46,057 | 41 payments
|
| DePuy Synthes Products | Emphasys | $8,848 | 13 payments
|
| Onkos Surgical | Eleos Limb Salvage System | $3,327 | 3 payments
|
| DePuy Synthes Sales | Emphasys | $102 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $36 | 1 payment
|
See all 59 published payments
| Smith+Nephew | Consulting · 2025-12-12 | None | $1,706 |
| Smith+Nephew | Consulting · 2025-12-11 | None | $263 |
| Smith+Nephew | Paid to speak or teach · 2025-11-21 | Real Intelligence | $9,188 |
| Smith+Nephew | Travel · 2025-11-21 | Real Intelligence | $76 |
| Smith+Nephew | Meals · 2025-11-21 | Real Intelligence | $16 |
| Smith+Nephew | Meals · 2025-11-15 | Polarstem | $93 |
| Smith+Nephew | Travel · 2025-11-14 | Journey II | $302 |
| Smith+Nephew | Travel · 2025-11-14 | Polarstem | $221 |
| Smith+Nephew | Travel · 2025-11-14 | Polarstem | $235 |
| Smith+Nephew | Meals · 2025-11-14 | Polarstem | $148 |
| DePuy Synthes Products | Consulting · 2025-11-06 | None | $6,300 |
| DePuy Synthes Products | Travel · 2025-11-06 | None | $76 |
| Smith+Nephew | Paid to speak or teach · 2025-10-29 | Or3o Dual Mobility | $2,888 |
| Smith+Nephew | Meals · 2025-10-24 | Real Intelligence | $24 |
| Smith+Nephew | Consulting · 2025-10-21 | None | $1,050 |
| DePuy Synthes Products | Consulting · 2025-10-13 | None | $675 |
| DePuy Synthes Products | Meals · 2025-10-09 | Emphasys | $8 |
| DePuy Synthes Products | Travel · 2025-10-08 | Emphasys | $195 |
| DePuy Synthes Products | Travel · 2025-10-08 | Emphasys | $161 |
| DePuy Synthes Products | Meals · 2025-10-07 | Emphasys | $37 |
| DePuy Synthes Products | Meals · 2025-10-07 | Emphasys | $25 |
| DePuy Synthes Products | Travel · 2025-10-07 | Emphasys | $195 |
| DePuy Synthes Products | Meals · 2025-10-07 | Emphasys | $10 |
| Onkos Surgical | Meals · 2025-09-28 | Eleos Limb Salvage System | $127 |
| Smith+Nephew | Consulting · 2025-09-27 | Real Intelligence | $11,156 |
| Smith+Nephew | Meals · 2025-09-25 | Real Intelligence | $49 |
| Smith+Nephew | Meals · 2025-09-25 | Real Intelligence | $95 |
| Vertex Pharmaceuticals | Meals · 2025-09-24 | Journavx | $36 |
| Smith+Nephew | Travel · 2025-09-20 | Journey II | $713 |
| Smith+Nephew | Meals · 2025-09-20 | Journey | $68 |
| Smith+Nephew | Meals · 2025-09-19 | Journey | $177 |
| Smith+Nephew | Meals · 2025-09-19 | Journey | $111 |
| Smith+Nephew | Travel · 2025-09-18 | Journey II | $591 |
| Smith+Nephew | Travel · 2025-09-18 | Journey | $226 |
| Smith+Nephew | Travel · 2025-09-18 | Journey | $673 |
| Smith+Nephew | Travel · 2025-09-18 | Journey | $136 |
| DePuy Synthes Sales | Meals · 2025-09-16 | Emphasys | $102 |
| Smith+Nephew | Meals · 2025-09-10 | Real Intelligence | $122 |
| DePuy Synthes Products | Travel · 2025-09-05 | Emphasys | $311 |
| DePuy Synthes Products | Travel · 2025-09-05 | Emphasys | $178 |
| Onkos Surgical | Consulting · 2025-08-20 | Eleos Limb Salvage System | $2,400 |
| Smith+Nephew | Consulting · 2025-08-02 | None | $1,444 |
| Smith+Nephew | Meals · 2025-07-17 | None | $122 |
| Smith+Nephew | Meals · 2025-06-28 | Real Intelligence | $61 |
| Smith+Nephew | Consulting · 2025-06-28 | Real Intelligence | $11,944 |
| Smith+Nephew | Travel · 2025-06-28 | Real Intelligence | $114 |
| DePuy Synthes Products | Consulting · 2025-06-27 | None | $675 |
| Smith+Nephew | Meals · 2025-06-14 | Journey II | $74 |
| Smith+Nephew | Meals · 2025-06-14 | Journey II | $11 |
| Smith+Nephew | Meals · 2025-06-13 | Journey II | $80 |
| Smith+Nephew | Meals · 2025-06-13 | Journey II | $117 |
| Smith+Nephew | Travel · 2025-06-12 | None | $671 |
| Smith+Nephew | Travel · 2025-06-12 | Journey II | $690 |
| Smith+Nephew | Travel · 2025-06-12 | Journey II | $51 |
| Smith+Nephew | Meals · 2025-06-12 | Journey II | $10 |
| Smith+Nephew | Travel · 2025-06-12 | Journey II | $78 |
| Smith+Nephew | Travel · 2025-06-12 | Journey II | $116 |
| Smith+Nephew | Meals · 2025-05-13 | None | $147 |
| Onkos Surgical | Consulting · 2025-02-14 | Eleos Limb Salvage System | $800 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $62,082
| Smith+Nephew | Or3o Dual Mobility | $39,246 | 38 payments
|
| Onkos Surgical | Eleos Limb Salvage System | $11,798 | 7 payments
|
| DePuy Synthes Products | Emphasys | $10,363 | 12 payments
|
| Medical Device Business Services | None | $675 | 1 payment
|
2023: $46,467
| Smith+Nephew | Or3o Dual Mobility | $35,267 | 35 payments
|
| Medical Device Business Services | Actis | $8,573 | 10 payments
|
| Onkos Surgical | Eleos Limb Salvage System | $2,400 | 2 payments
|
| DePuy Synthes Sales | Velys | $135 | 1 payment
|
| Stryker | Triathlon | $92 | 2 payments
|
2022: $54,249
| Smith+Nephew | Anthology | $44,769 | 46 payments
|
| Medical Device Business Services | Attune | $9,480 | 11 payments
|
2021: $231
| Smith+Nephew | Or3o | $138 | 2 payments
|
| DePuy Synthes Sales | Velys | $93 | 1 payment
|
2020: $37
| Medical Device Business Services | Attune | $37 | 2 payments
|
2019: $6,999
| Medical Device Business Services | Actis | $6,763 | 13 payments
|
| Smith+Nephew | Journey II Bcs | $140 | 1 payment
|
| Biocomposites | Stimulan | $47 | 1 payment
|
| Stryker | Mako | $31 | 1 payment
|
| Mallinckrodt Enterprises | Ofirmev | $18 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Smith+Nephew, Inc. · A Multi-Center Study in Patients Undergoing Total Hip Arthroplast With Smith & Nephew Catalystem Promary Hip · 2025 | Their institution | $40,007 |
| Smith+Nephew, Inc. · A Multi-Center Study in Patients Undergoing Total Hip Arthroplast With Smith & Nephew Catalystem Promary Hip · 2024 | Their institution | $3,080 |
Professional record
- NPI
- 1598031304
- Licence
- CA A128858, NC 2017-00172California A128858: Current · expires 2028-01-31
- Group
- University of California San Francisco · UCSF Medical Group Business Services · Regents Univ of California UCSF
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NC 1598031304, SC NC3021
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 500 Parnassus Ave, Mu323w, San Francisco, CA, 94143
- NPI first listed
- 2012-03-26
- NPI last updated
- 2021-12-06
- NPI record certified
- 2021-12-06
This is when the NPI record was last certified, not a medical board exam.